Abacus Life (ABL) Closes Two Key Acquisitions, Well Positioned For 2025

This is sponsored content.  Barchart is not endorsing the websites or products set forth below.

Abacus Life (ABL) – a pioneering global alternative asset manager specializing in leveraging longevity data and actuarial technology to offer uncorrelated investment opportunities recently finalized two major acquisitions which position the company to continue its financial success in 2025. These two acquisitions, along with Abacus Life’s strong performance in 2024, helped the company secure four Buy Ratings from prominent stock analysts in recent months.

This article will explore Abacus Life’s two recent acquisitions as well as the company’s promising position in the market for 2025.

Acquisition #1: Carlisle Management Company S.C.A.

Abacus Life’s acquisition of Carlisle Management Company S.C.A., a Luxembourg-based global investment management firm, will provide ABL with a presence in international markets, helping transform the company from a US leader to a global player.  

Now that the acquisition has closed, Carlisle’s investors will be able to access Abacus Life’s suite of insurance-based investments. In total, this acquisition will add roughly $2 billion in assets under management (AUM) to the company’s ABL Wealth Division. 

This acquisition closely aligns with Abacus Life’s strategy to drive long-term growth and diversify its value proposition through expanded global alternative asset-management offerings.

Acquisition #2: FCF Advisors 

While the Carlisle acquisition helped to expand Abacus Life’s presence in global markets, the company’s acquisition of FCF Advisors helps expand its suite of products.

FCF Advisors is a New York-based asset management firm and index provider that will bring roughly $850 million into the ABL Wealth division. The company’s core offering is thematic free cash flow investments and the company offers over 50 total customizable index strategies across 8 global categories. This acquisition is highly complementary to Abacus Life’s existing offerings and will help the company deliver a more comprehensive suite of lifespan-based investment solutions to its clients as well as increase its market share.

Looking towards 2025

In addition to these strategic acquisitions, Abacus Life has seen substantial growth in revenue, product development, and key hires in 2024. This was reflected in their Q3 earnings report, in which the company reported a 33% year-over-year increase in revenue to $28.1 million. Adjusted net income for the quarter climbed 65% to $14.9 million.

As the only publicly traded life settlement company in the United States, Abacus Life specializes in purchasing life insurance policies from individuals who need liquidity. They then manage these policies through various strategies, such as trading, holding, or servicing them.  By doing so, Abacus Life creates a unique investment opportunity that offers stable returns and is relatively insulated from traditional market risks.  

As the company expands its global footprint and diversifies its product offerings, it is well positioned in 2025 to capitalize on the growing demand for alternative investments and to weather potential economic uncertainties.

To learn more about Abacus Life, visit www.abacuslife.com.

Disclaimers: This presentation has been created by Barchart Impact and is responsible for the distribution of this content. This presentation should be considered and explicitly regarded as sponsored content. Barchart Impact has been compensated up to four thousand dollars to create this content. Accordingly, this content may be used and syndicated beyond the channels used by Barchart Impact. This disclaimer and the link to the broader disclosures must be part of all reproductions. That compensation creates a conflict of interest because the content presented may only provide a favorable viewpoint of the company featured. The information in this article is not intended to be, nor does it constitute, investment advice or recommendations. Never take opinions, articles presented, interviews, or content provided as the sole reason to invest in any featured company. Investors must always perform their own due diligence before investing in any publicly traded company and understand the risks involved, including losing their entire investment. 

The above is sponsored content. Barchart was paid up to four thousand dollars for placement and promotion of the content on this site and other forms of public distribution covering the period of November 2024.  For more information please view the Barchart Disclosure Policy here.